Immunity against mouse thymus-leukemia antigen (TL) protects against development of lymphomas induced by a chemical carcinogen, N-butyl-N-nitrosourea

スポンサーリンク

概要

論文の詳細を見る
2004-11-10

著者

関連論文

Reconstitution of HLA-A^*2402-Restricted Cytomegalovirus-Specific T-Cells following Stem Cell Transplantation
CD56/NCAM-Positive Langerhans Cell Sarcoma : A Clinicopathologic Study of 4 Cases
Phenotypic analysis of peripheral T/NK cell lymphoma : Study of 408 Japanese cases with special reference to their anatomical sites
Depletion of Thymus-Derived CD4^+CD25^+ T Cells Abrogates the Suppressive Effects of α-galactosylceramide Treatment on Experimental Allergic Conjunctivitis
Localization of Gelatinolytic Activity Can Be Detected in Breast Cancer Tissues by Film in situ Zymography
Limited association between a catechol-O-methyltransferase (CONT) polymorphism and breast cancer risk in Japan
No Association of the 5' Promoter Region Polymorphism of CYP17 with Breast Cancer Risk in Japan
Identification of Cancer Antigens in Breast Cancer by the SEREX Expression Cloning Method
Novel Functions of Herbal Medicines in Dendritic Cells : Role of Amomi Semen in Tumor Immunity
CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy
Epstein-Barr virus nuclear antigen 1-specific CD4^+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells
Aberrant expression of BCL2A1-restricted minor histocompatibility antigens in melanoma cells : application for allogeneic transplantation
Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions
Immunity against mouse thymus-leukemia antigen (TL) protects against development of lymphomas induced by a chemical carcinogen, N-butyl-N-nitrosourea
Thymus-leukemia antigen (TL) as a major histocompatibility complex (MHC) class Ib molecule and tumor-specific antigen
Thymus leukemia antigen (TL)-specific cytotoxic T lymphocytes recognize the α1/α2 domain of TL free from antigenic peptides
Comparison of Anti-Tumor Responses against TL Positive Lymphoma Induced by Skin Grafting and Dendritic Cell Immunization
Murine Delta Homologue, mDelta1, Expressed on Feeder Cells Controls Cellular Differentiation
The epitope detected by cytotoxic T lymphocytes against thymus leukemia (TL) antigen is TAP independent
Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1
Different Susceptibilities of Postmitotic Checkpoint-proficient and-deficient Balb/3T3 Cells to ICRF-193, a Catalytic Inhibitor of DNA Topoisomerase II
NF-κB is required for CD38-mediated induction of C_γ1 germline transcripts in murine B lymphocytes
Recombinant Cholera Toxin B Subunit Activates Dendritic Cells and Enhances Antitumor Immunity
Mismatched human leukocyte antigen class II-restricted CD8^+ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation
Glypican-3 could be an effective target for immunotherapy combined with chemotherapy against ovarian clear cell carcinoma

もっと見る

スポンサーリンク